Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1426.80
-11.95 (-0.83%) Cipla - Quaterly Results
Date: 10-05-2022
The company witnessed a 11.44% growth in the revenue at Rs. 29466.10 millions for the quarter ended March 2022 as compared to Rs. 26442.00 millions during the year-ago period.A humble growth in net profit of 13.50% reported in the quarter ended March 2022 to Rs. 4763.00 millions from Rs. 4196.60 millions.Operating profit for the quarter ended March 2022 rose to 7039.60 millions as compared to 6875.80 millions of corresponding quarter ended March 2021.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202203 | 202103 | % Var | 202203 | 202103 | % Var | 202203 | 202103 | % Var | |
| Sales | 29466.10 | 26442.00 | 11.44 | 130917.90 | 113027.10 | 15.83 | 130917.90 | 113027.10 | 15.83 |
| Other Income | 3163.10 | 493.30 | 541.21 | 6667.00 | 2302.80 | 189.52 | 6667.00 | 2302.80 | 189.52 |
| PBIDT | 7039.60 | 6875.80 | 2.38 | 40331.70 | 32976.90 | 22.30 | 40331.70 | 32976.90 | 22.30 |
| Interest | 57.80 | 88.40 | -34.62 | 269.30 | 450.70 | -40.25 | 269.30 | 450.70 | -40.25 |
| PBDT | 6981.80 | 6787.40 | 2.86 | 40062.40 | 32526.20 | 23.17 | 40062.40 | 32526.20 | 23.17 |
| Depreciation | 1168.20 | 1177.50 | -0.79 | 4600.10 | 4686.20 | -1.84 | 4600.10 | 4686.20 | -1.84 |
| PBT | 5813.60 | 5609.90 | 3.63 | 35462.30 | 27840.00 | 27.38 | 35462.30 | 27840.00 | 27.38 |
| TAX | 1050.60 | 1413.30 | -25.66 | 8568.40 | 7393.50 | 15.89 | 8568.40 | 7393.50 | 15.89 |
| Deferred Tax | -35.00 | 92.80 | -137.72 | -304.00 | -169.20 | 79.67 | -304.00 | -169.20 | 79.67 |
| PAT | 4763.00 | 4196.60 | 13.50 | 26893.90 | 20446.50 | 31.53 | 26893.90 | 20446.50 | 31.53 |
| Equity | 1613.60 | 1612.90 | 0.04 | 1613.60 | 1612.90 | 0.04 | 1613.60 | 1612.90 | 0.04 |
| PBIDTM(%) | 23.89 | 26.00 | -8.13 | 30.81 | 29.18 | 5.59 | 30.81 | 29.18 | 5.59 |